Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.
Reset all filters
01 2Rusan Pharma
02 1AbbVie Inc
03 2Dr. Reddy's Laboratories
04 4ABRAXIS PHARM
05 1Abbott Laboratories
06 2Aboca
07 2Cooper Pharma Limited
08 5ENDO OPERATIONS
09 1Farbe Firma
10 1Farmak JSC
11 1Hana Pharm
12 4Hospira, Inc.
13 8IGI Labs, Inc.
14 1Instituto Biologico Contemporaneo
15 2Madras Pharmaceuticals
16 1Myungmoon Pharm. Co., LTD.
17 1Orpha-Devel Handels und
18 2Quad Pharma
19 4Rising Pharmaceuticals Inc
20 1Sandoz B2B
21 4Somerset Pharmaceuticals Inc
22 1Square Pharmaceuticals
23 2Verve Human Care Laboratories
Reset all filters
01 2INJ
02 1INJECTABLE;INJECTION
03 2INJECTION
04 2Injectable; Injection
05 11Injection
06 1SOLUTION
07 1SOLUTION FOR INJECTION
08 32SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
09 1Solution for Injection
Reset all filters
01 25DISCN
02 3Generic
03 1Generic B.E study
04 8RX
05 1Schedule G (CDSA IV)
06 15Blank
Reset all filters
01 5NALBUPHINE
02 25NALBUPHINE HYDROCHLORIDE
03 2NALBUVER
04 5NUBAIN
05 1NUBAIN INJECTION 10MG/ML
06 1Nalbain Injection 10mg/ml
07 1Nalbuk
08 1NalbuphineHCI
09 2Nalpain
10 1Nlabain Injection 20mg/ml
11 1Radirif
12 8Blank
Reset all filters
01 1Argentina
02 1Bangladesh
03 1Canada
04 9India
05 2South Africa
06 2South Korea
07 1Sweden
08 35USA
09 1Ukraine
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 10mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALBUPHINE HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 1.5MG/ML
Packaging :
Approval Date : 1993-03-12
Application Number : 20200
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALBUPHINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/10ML (10MG/ML)
Packaging :
Approval Date : 1998-03-19
Application Number : 74471
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 20mg/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALBUPHINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 200MG/10ML (20MG/ML)
Packaging :
Approval Date : 1998-03-19
Application Number : 74471
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALBUPHINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 20MG/ML (20MG/ML)
Packaging :
Approval Date : 1989-02-03
Application Number : 70917
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALBUPHINE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 10MG/ML (10MG/ML)
Packaging :
Approval Date : 1986-07-02
Application Number : 70751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALBUPHINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/10ML (10MG/ML)
Packaging :
Approval Date : 1986-07-02
Application Number : 70751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALBUPHINE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 20MG/ML (20MG/ML)
Packaging :
Approval Date : 1986-09-24
Application Number : 70752
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NALBUPHINE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 200MG/10ML (20MG/ML)
Packaging :
Approval Date : 1986-09-24
Application Number : 70752
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALBUPHINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 10MG/ML (10MG/ML)
Packaging :
Approval Date : 1989-02-03
Application Number : 70914
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALBUPHINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/10ML (10MG/ML)
Packaging :
Approval Date : 1989-02-03
Application Number : 70915
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NALBUPHINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 20MG/ML (20MG/ML)
Packaging :
Approval Date : 1989-02-03
Application Number : 70916
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NALBUPHINE
Dosage Form : Injectable; Injection
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number : 70692
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NALBUPHINE
Dosage Form : Injectable; Injection
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 70693
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NUBAIN
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 10MG/ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 18024
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NUBAIN
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 20MG/ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-05-27
Application Number : 18024
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NUBAIN
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/10ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 18024
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NUBAIN
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 20MG/2ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 18024
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : NUBAIN
Dosage Form : SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 200MG/10ML (20MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1984-03-02
Application Number : 18024
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF